Intelligence · Clinical Pipeline
Teva Pharma Pipeline
All ClinicalTrials.gov programs at Teva Pharma — phase, modality, and trial IDs.
- Programs
- 154
Quick answer
Teva Pharma has 154 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Paroxetine HCl
Teva Pharma GmbH
Healthy
2 trials -
Pramipexole Dihydrochloride
Teva Pharma GmbH
Healthy
2 trials -
Pravastatin sodium 80 mg tablets
Teva Pharma GmbH
Healthy
1 trial -
Progesterone vaginal ring,
Teva Pharma GmbH
Pharmacokinetics
1 trial -
Ramipril 10 mg capsule
Teva Pharma GmbH
Healthy
3 trials -
Reslizumab IV
Teva Pharma GmbH
Absolute Bioavailability
1 trial -
Ribavirin 200 mg tablets
Teva Pharma GmbH
Healthy
2 trials -
Risperidone
Teva Pharma GmbH
Healthy
2 trials -
Ropinirole HCl 0.25 mg Tablets
Teva Pharma GmbH
Healthy
2 trials -
Rowasa® 4 gm/60 mL Rectal Enema
Teva Pharma GmbH
Healthy
1 trial -
SD-809
Teva Pharma GmbH
TOURETTE SYNDROME
1 trial -
Sublingual Tizanidine HCl
Teva Pharma GmbH
Traumatic Brain Injury
1 trial -
Sumatriptan succinate
Teva Pharma GmbH
Migraine Disorders
1 trial -
Sumatriptan succinate
Teva Pharma GmbH
Healthy
3 trials -
TAK-573
Teva Pharma GmbH
Relapsed and/or Refractory Multiple Myeloma
1 trial -
TEV-48125 - 1
Teva Pharma GmbH
Pharmacokinetics
1 trial -
TEV-53408
Teva Pharma GmbH
Vitiligo
1 trial -
TEV-56278
Teva Pharma GmbH
Advanced Solid Tumors
1 trial -
TEV-56286
Teva Pharma GmbH
Healthy Participants
1 trial -
TEV-56286 Test
Teva Pharma GmbH
Healthy Participants
1 trial -
TL011
Teva Pharma GmbH
DLBCL
1 trial -
TL011, anti CD20, for the treatment of rheumatoid arthritis
Teva Pharma GmbH
Rheumatoid Arthritis
1 trial -
TV-45070
Teva Pharma GmbH
Pharmacokinetics
1 trial -
TV-46046
Teva Pharma GmbH
Contraception
2 trials -
TV-46046 - 400 mg/mL
Teva Pharma GmbH
Pregnancy
1 trial -
TV46017
Teva Pharma GmbH
Chronic Obstructive Pulmonary Disease (COPD
1 trial -
TV48108
Teva Pharma GmbH
Chronic Obstructive Pulmonary Disease
1 trial -
Talampanel
Teva Pharma GmbH
Healthy
1 trial -
Talampanel (non-radiolabeled), [14C] Talampanel
Teva Pharma GmbH
Healthy
1 trial -
Tamsulosin
Teva Pharma GmbH
Healthy
2 trials -
Terbinafine HCl 250mg tablets
Teva Pharma GmbH
Healthy
2 trials -
Topiramate 2 x 25 mg tablet
Teva Pharma GmbH
Healthy
1 trial -
Topiramate 25 mg Capsules
Teva Pharma GmbH
Healthy
1 trial -
Topiramate Capsules, 25 mg
Teva Pharma GmbH
Healthy
2 trials -
Topiramate Tablets
Teva Pharma GmbH
Healthy
1 trial -
Trandolapril 4 mg Tablets
Teva Pharma GmbH
Healthy
2 trials -
Treatment A: Fp MDPI
Teva Pharma GmbH
Asthma
1 trial -
Ursodiol
Teva Pharma GmbH
Healthy
2 trials -
Valacyclovir
Teva Pharma GmbH
Healthy
2 trials -
Venlafaxine 25 mg Tablets
Teva Pharma GmbH
Healthy
2 trials -
Venlafaxine Hydrochloride
Teva Pharma GmbH
Healthy
3 trials -
XM17
Teva Pharma GmbH
Bioequivalence
1 trial -
Zaleplon 10 mg Capsules
Teva Pharma GmbH
Healthy
2 trials -
Zithromax®
Teva Pharma GmbH
Healthy
1 trial -
Zoloft® 100 mg Tablets
Teva Pharma GmbH
Healthy
2 trials -
Zolpidem 10 mg tablets
Teva Pharma GmbH
Healthy
2 trials -
a 60 mg dose of the hydrocodone bitartrate extended-release tablet administered as either two 30-mg tablets (Treatment A) or one 60-mg tablet (Treatment B).
Teva Pharma GmbH
Pain
1 trial -
amoxicillin-clavulanic acid
Teva Pharma GmbH
Healthy
2 trials
Frequently asked questions
How many pipeline programs does Teva Pharma have?
154 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs